Navigation Links
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
Date:8/30/2012

tel in New York, New York. These panel presentations will not be webcast.About Arena Pharmaceuticals
Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs for weight management, cardiovascular disease, inflammation and other disorders. Arena's US operations are located in San Diego, California, and its operations outside of the United States, including its commercial manufacturing facility, are located in Zofingen, Switzerland. For more information about Arena, please visit www.arenapharm.com.

Arena Pharmaceuticals® and Arena® are registered service marks of Arena Pharmaceuticals, Inc.

Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's efforts, focus, goals, strategy, research and development programs, and ability to discover and develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: risks related to commercializing drugs, including regulatory, manufacturing and supply issues and the pace of market acceptance; cash and revenues generated from lorcaserin, including the timing and impact of competition; the timing and outcome of regulatory review is uncertain; government and commercial reimbursement and pricing decisions; risks related to relying on collaborative agreements; the timing and receipt of payments and fees, if any, from collaborators; the entry into, modification or termination of collaborative arrangements; unexpected or unfavorabl
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
2. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
3. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
4. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
5. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
6. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
7. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
9. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
11. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Transparency Market Research (TMR) has announced the ... Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends ... this report, the global cancer diagnostics market is expected to ... of 2014 to 2020. In 2013, the global cancer diagnostics ... be worth US$168,649.3 million by 2020.The increasing prevalence of cancer ...
(Date:7/28/2015)... , July 28, 2015   CSL ... for review a Marketing Authorization Application (MAA) for ... coagulation factor IX with recombinant albumin (rIX-FP) for ... people with Hemophilia B. Upon Swissmedic approval, rIX-FP ... treatment option with dosing intervals up to 14 ...
(Date:7/28/2015)... 28, 2015  Today, Sekisui Diagnostics announces the launch ... efficient instrument, with a broad menu of high quality ... the physicians, office or hospital laboratory. ... tests/hour with ISE, 72 patient sample on-board capability, minimizes ... assays (+3 ISE) to meet the testing needs of ...
Breaking Medicine Technology:Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4Sekisui Diagnostics Announces Launch of SK500 Clinical Chemistry System for US Laboratories 2
... Pharmaceuticals, Inc. (NASDAQ: QCOR ) today announced ... on Tuesday, April 26, 2011 after the close of ... conference call and webcast on Tuesday, April 26, 2011 ... discuss results and highlights of the first quarter, as ...
... China Medical Equipment Fair, (CMEF) -- United ... MRI systems in China, is introducing its iuStar100 ... iuStar100 utilizes Samplify,s high-performance, low-power receiver analog front-end ... converter (ADC) to deliver exceptional B-mode and color ...
Cached Medicine Technology:Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011 2United Imaging Healthcare Leverages Samplify's Analog Front-End Solutions to Deliver New Portable Ultrasound System with Superior Image Quality 2
(Date:7/28/2015)... ... July 29, 2015 , ... The insurance telematics or usage-based insurance (UBI) ... insurers to access the on-board vehicle data and better understand customer behavior behind the ... sharing vehicle data. However times are changing and automakers realize that with the Internet ...
(Date:7/28/2015)... Aliso Viejo, CA (PRWEB) , ... July 28, 2015 , ... ... within Final Cut Pro X . With ProFont: Cursive users can generate a ... character is fully customizable leaving endless stylization. Users can select from either the upper ...
(Date:7/28/2015)... Rolling Meadows, Ill. (PRWEB) , ... July 28, 2015 , ... ... has been commended with a national 2015 Power of A award for “helping to ... named a Power of A Gold Award winner by the American Society of Association ...
(Date:7/28/2015)... ... July 28, 2015 , ... World Patent Marketing, ... household invention that cleans pools efficiently - minus the backbreaking work. , "The ... and Creative Director of World Patent Marketing. "It is a sleeping giant that ...
(Date:7/28/2015)... ... ... Mindful Her, a unique women’s wellness and lifestyle event designed to inspire ... to the next level, announced today an influential line-up of inspiring speakers, including Mallika ... Girls, an Orange County based non-profit that works locally and globally to help girls ...
Breaking Medicine News(10 mins):Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3Health News:Announcing ProFont Cursive from FCPX Effects developer Pixel Film Studios 2Health News:ASDS Skin Cancer Program Honored 2Health News:ASDS Skin Cancer Program Honored 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3
... 2011 In a multicenter clinical trial, UT ... doses of stereotactic radiation therapy requiring fewer treatments ... prostate cancer. Results of the trial, available ... showed that stereotactic body radiation therapy (SBRT), which ...
... ― A vaccine for one of the most lethal cancers, ... patients when combined with the immunotherapy drug Interleukin-2, according to ... Anderson Cancer Center and Indiana University Health Goshen Center for ... 2 New England Journal of Medicine , mark the ...
... people were due solely to the existence of genetic changes, ... discoveries made during these last ten years show that beings ... may have different characteristics and disease due to epigenetic changes. ... and proteins that package it, to regulate their activity. The ...
... Salamon HealthDay Reporter , WEDNESDAY, June 1 (HealthDay ... entrenched in the human lineage for far longer than thought, ... to determine their geographic movement. Scientists from the University ... species that roamed the South African savanna more than a ...
... precise form of radiation therapy, causes fewer gastrointestinal ... using three-dimensional radiation therapy, according to a study ... International Journal of Radiation OncologyBiologyPhysics , the official ... Oncology (ASTRO). Three-dimensional radiation therapy (3D-CRT) combined ...
... Denver Health, Intermountain Healthcare, Dartmouth-Hitchcock, Cleveland Clinic, and ... Practice (TDI) announced the formation of the High ... lower costs, and move best practices out to ... eight major health systems will join the Collaborative. ...
Cached Medicine News:Health News:Higher doses of radiation in fewer treatments proved safe, effective for low-risk prostate cancer 2Health News:Therapeutic melanoma vaccine improves response rate, progression-free survival 2Health News:Therapeutic melanoma vaccine improves response rate, progression-free survival 3Health News:Researchers characterize epigenetic fingerprint of 1,628 people 2Health News:Even Ancient Men Seemed to Like Their Man Caves 2Health News:National High Value Healthcare Collaborative expands 2
Bechert-McPherson tying forceps, angled, 10 mm tying platforms....
Girard curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 99 mm....
Curved tying forceps made of titanium has curved shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 103 mm....
Straight tying spring forceps made of titanium, delicate smooth jaws, length 10 mm, TCI jaws with round handle, diam. 8 mm and overall length 115 mm....
Medicine Products: